Compounds > draflazine
Page last updated: 2024-08-24

draflazine and Heart Disease, Ischemic

draflazine has been researched along with Heart Disease, Ischemic in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Belle, H1
Aksnes, G; Christensen, G; Ilebekk, A; Kirkebøen, KA; Leistad, E; Naess, PA; Tønnessen, T1
Grover, GJ; Sleph, PG1
Parratt, JR; Van Belle, H; Wainwright, CL1
Galiñanes, M; Hearse, DJ; Qiu, Y; Van Belle, H1
Grund, F; Ilebekk, A; Jynge, P; Kirkebøen, KA; Offstad, J; Sommerschild, HT1
Deindl, E; Ilebekk, A; Jynge, P; Kirkebøen, KA; Lunde, PK; Sommerschild, HT1

Other Studies

7 other study(ies) available for draflazine and Heart Disease, Ischemic

ArticleYear
Myocardial protection by nucleoside transport inhibition.
    Transplantation proceedings, 1995, Volume: 27, Issue:5

    Topics: Adenine Nucleotides; Adenosine; Animals; Biological Transport; Cardiotonic Agents; Heart; Humans; In Vitro Techniques; Myocardial Ischemia; Myocardium; Piperazines

1995
Cardiac contractile function following repetitive brief ischemia: effects of nucleoside transport inhibition.
    The American journal of physiology, 1994, Volume: 267, Issue:1 Pt 2

    Topics: Animals; Biological Transport; Female; Hemodynamics; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Stunning; Nucleosides; Piperazines; Swine; Systole

1994
The cardioprotective effects of R 75231 and lidoflazine are not caused by adenosine A1 receptor activation.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:1

    Topics: Animals; Coronary Circulation; Heart; Lidoflazine; Male; Myocardial Ischemia; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1

1994
The antiarrhythmic effects of the nucleoside transporter inhibitor, R75231, in anaesthetized pigs.
    British journal of pharmacology, 1993, Volume: 109, Issue:2

    Topics: Adenosine; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Coronary Vessels; Dose-Response Relationship, Drug; Electrocardiography; Myocardial Ischemia; Nucleosides; Piperazines; Swine; Ventricular Fibrillation; Ventricular Function

1993
Metabolic and functional effects of the nucleoside transport inhibitor R75231 in the ischaemic and blood reperfused rabbit heart.
    Cardiovascular research, 1993, Volume: 27, Issue:1

    Topics: Adenine Nucleotides; Adenosine; Animals; Biological Transport, Active; Coronary Vessels; Female; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nucleosides; Piperazines; Rabbits; Regional Blood Flow; Vascular Resistance

1993
Importance of endogenous adenosine during ischemia and reperfusion in neonatal porcine hearts.
    Circulation, 1997, Nov-04, Volume: 96, Issue:9

    Topics: Adenosine; Animals; Animals, Newborn; Creatine Kinase; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Piperazines; Swine; Theophylline

1997
Elevated levels of endogenous adenosine alter metabolism and enhance reduction in contractile function during low-flow ischemia: associated changes in expression of Ca(2+)-ATPase and phospholamban.
    Journal of molecular and cellular cardiology, 1999, Volume: 31, Issue:10

    Topics: Adenosine; Animals; Calcium-Binding Proteins; Calcium-Transporting ATPases; Cardiotonic Agents; Energy Metabolism; Female; Gene Expression Regulation; Heart; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Oxygen Consumption; Piperazines; Swine; Theophylline; Ventricular Function, Left

1999